Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease

doi:10.3748/wjg.v28.i35.5111

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 35

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5626)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

339

WORD

HTML

2885

Tables (1-3)

391

Sum=3682

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

178

Download

508

Sum=686

Publishing Process of This Article

Item

Count

Browse

380

Download

878

Sum=1258

Sep 21, 2022 (publication date) through Feb 15, 2025

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Sep 21, 2022; 28(35): 5111-5128
Published online Sep 21, 2022. doi: 10.3748/wjg.v28.i35.5111

Table 3 Relevant dysregulated circular RNAs associated with alterations in liver metabolism and nonalcoholic fatty liver disease

circRNA	Expression level	Main functional and pathophysiological effects	Ref.
circRNA_0046367	↑	Inhibits hepatic steatosis by preventing hepatotoxicity of lipid peroxidation	[148]
circRNA_0046366	↑	Inhibits hepatic steatosis through miR-34a/PPARα	[149]
circRNA_021412	↑	Associated with hepatic steatosis	[150]
circScd1	↓	Affects steatosis on NAFLD via JAK2/STAT5 signaling pathways	[151]
hsa_circ_0048179	↓	Attenuates free fatty acid-induceded steatosis by sponging of miR-188-3p in vitro	[152]
mmu_circRNA_29981	↑	Regulatory role in NASH mousee model	[153]
Circ_0057558	↑	Involved in lipogenesis	[156]
Circ_0057558	↑	Promotes nonalcoholic fatty liver disease by sponging miR-206	[156]
SCAR	↓	Correlates with steatosis-to-NASH progression	[157]
SCAR	↓	In vivo, targeting circRNA SCAR alleviates HFD-induced cirrhosis and insulin resistance	[157]

circRNAs: Circular RNAs; HCC: Hepatocellular carcinoma; HFD: High-fat diet; JAK2: Janus Kinase 2; NAFLD: Nonalcoholic fatty liver disease; NASH: Nonalcoholic steatohepatitis; PPARα: Peroxisome proliferator-activated receptor α; STAT5: Signal transducer and activator of transcription 5.

Citation: Zaiou M. Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease. World J Gastroenterol 2022; 28(35): 5111-5128
URL: https://www.wjgnet.com/1007-9327/full/v28/i35/5111.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i35.5111